News Archives - Page 5 of 9 - Precision Pathology

SA cancer test maker strikes deal with global medical device company

OCTOBER 15, 2020 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San-Antonio Business Journal BioAffinity Technologies has teamed with a global medical device manufacturer, Smiths Medical, to expand the commercial reach and viability of the San Antonio-based company’s CyPath Lung® diagnostic cancer detection test. Under the agreement, bioAffinity […]

Inspirational Women Leaders of Tech: Maria Zannes of bioAffinity Technologies On The Five Things You Need To Know In Order To Create A Very Successful Tech Company

SEPTEMBER 26, 2020 By Douglas Brown, Authority Magazine Follow the science. Businesspeople rightfully seek to control a situation, but that does not bode well in the science field. Mother nature has a way of surprising you. Innovation is essential to a biotech company, but it does not reveal itself if you have a limited view […]

BioAffinity Technologies CEO Maria Zannes talks cancer detection, women in medtech

SEPTEMBER 24, 2020 Originally published in Medical Design & Outsourcing by Sean Whooley.   Maria Zannes and her company BioAffinity Technologies are seeking to up the game on lung cancer detection. Here’s how. Maria Zannes’ path to a leading role in the medtech field wasn’t quite a conventional one. The one-time aspiring journalist carved out a […]

SA Biotech Nearing Launch of Breakthrough Cancer Test

AUGUST 11, 2020 As published in the San Antonio Business Journal By W. Scott Bailey – Senior Reporter, San Antonio Business Journal A local pathology practice has initiated a validation study of San Antonio-based bioAffinity Technologies’ CyPath Lung early detection cancer test. The validation study is needed for bioAffinity to commercialize the product, which is […]

SA has More Room for Women in Bioscience C-suite

AUGUST 29, 2019 As published in the San Antonio Business Journal By W. Scott Bailey  – Senior Reporter, San Antonio Business Journal While there is acknowledgment that women have made progress in their climb to executive-level positions in San Antonio’s bioscience industry and may find fewer roadblocks here than in some markets, some of the local women leaders in […]

bioAffinity named a finalist in the Lyfebulb Helsinn 2019 Innovation Summit in Oncology

BioAffinity Technologies is proud to be named a finalist in the Lyfebulb Helsinn 2019 Innovation Summit in Oncology. Lyfebulb-Helsinn Innovation Summit March 18 and 19, 2019 Monaco,  Principality of Monaco Ten finalists will compete at the second annual Lyfebulb-Helsinn Innovation Summit. The second annual Lyfebulb-Helsinn Innovation Award will be presented to an exceptional innovator with outstanding entrepreneurial potential […]